Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Fluvoxamine Stories

2013-03-14 08:29:31

Company Awarded 180 Days Marketing Exclusivity for 150 mg Strength WOODCLIFF LAKE, N.J., March 14, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for fluvoxamine maleate 100 mg and 150 mg extended-release (ER) capsules. Fluvoxamine maleate ER is the generic version of Jazz Pharmaceuticals' Luvox CR(®) and is indicated for the...

2013-01-02 16:22:38

DUBLIN, Jan. 2, 2013 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will webcast its presentation at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, 2013. The webcast is scheduled to begin at 10:00 a.m. PST (6:00 p.m. GMT). Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals, will present an overview of the company and provide a business and financial update. The webcast can be...

2012-12-04 16:26:52

DUBLIN, Dec. 4, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the United States Patent and Trademark Office has issued a patent related to the use of Xyrem® (sodium oxybate) oral solution for the treatment of narcolepsy, titled "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy." The new patent, number 8,324,275, will be submitted for listing in the FDA's Approved Drug Products With Therapeutic...

2012-10-15 15:23:45

DUBLIN, Oct. 15, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the closing of the sale of its women's health business to Meda (an international specialty pharmaceutical company) for $95 million in cash. The products included in the sale are Elestrin(®) (estradiol gel), Gastrocrom(®) (cromolyn sodium, USP), Natelle(® )One (prenatal vitamin), AVC(TM) Cream (sulfanilamide), Gesticare(®) DHA (prenatal multi-vitamin) and Urelle(®) (urinary...

2012-09-12 02:29:52

POINT RICHMOND, Calif., Sept. 12, 2012 /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive disorder (OCD) who have not adequately responded to first-line treatment with an approved OCD medication. The Company plans to announce top-line results of this study in the first quarter of 2013. (Logo:...

2012-09-06 14:22:32

DUBLIN, Sept. 6, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will participate at the 2012 Morgan Stanley Global Healthcare Conference in New York on Tuesday, September 11, 2012 at 9:45 a.m. EST / 2:45 p.m. GMT. Kate Falberg, executive vice president and chief financial officer, will provide a business update during a question and answer session with an analyst. A live webcast of the presentation may be accessed from the Investors section of...

2012-07-31 02:28:19

DUBLIN, July 31, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Tuesday, August 7, 2012 at 4:30 p.m. EDT/9:30 p.m. IST. During the call, company management will provide a business and financial update and review second quarter 2012 results. A live webcast of presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the...

2012-06-05 14:21:19

DUBLIN, June 5, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the company will make a presentation at the Jefferies 2012 Global Healthcare Conference in New York on Thursday, June 7, 2012 at 8:00 a.m. EST/ 1:00 p.m. GMT. Bruce Cozadd, Chairman and Chief Executive Officer, will provide a business update. A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please...

2012-04-30 14:21:22

DUBLIN, April 30, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Tuesday, May 8, 2012 at 4:30 p.m. EDT/9:30 p.m. IST. During the call, company management will provide a business and financial update and review first quarter 2012 results. A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the...

2012-02-14 16:07:00

DUBLIN, Feb. 14, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will host a conference call and live webcast on Monday, February 27, 2011 at 4:30 p.m. EST/9:30 p.m. GMT. During the call, company management will provide a business update and review fourth quarter and full year 2011 financial results. The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals' website at www.jazzpharmaceuticals.com....